Dong-liang Yuan, Wen-qing Xie, Miao He, Deng-jie Yu, Heng-zhen Li, Hong-fu Jin, Guang Yang, Bing-zhou Ji, Wen-feng Xiao, Yu-sheng Li
{"title":"痛症、肌肉疏松症与肌肉杂志》的出版趋势与热点:文献计量分析(2010-2022 年)","authors":"Dong-liang Yuan, Wen-qing Xie, Miao He, Deng-jie Yu, Heng-zhen Li, Hong-fu Jin, Guang Yang, Bing-zhou Ji, Wen-feng Xiao, Yu-sheng Li","doi":"10.1002/rco2.88","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The <i>Journal of Cachexia, Sarcopenia and Muscle</i> is a quarterly peer-reviewed medical journal published by WILEY since 2010 and has been dedicated to advancing research on chronic diseases, especially cachexia and sarcopenia. Over the past 12 years, sarcopenia research worldwide has significantly changed. This study aimed to investigate different aspects of studies published in this journal.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Using the term ‘Journal of Cachexia, Sarcopenia and Muscle’, we retrieved related publications from the Web of Science and PubMed databases. Studies published in this journal were classified and analysed from different perspectives, such as the number of studies, total citations, times cited per item, H-index, research area, article types, institutions, country and funding agency. The VOS viewer software was used for co-occurrence, bibliographic coupling, co-citation and co-authorship analyses.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>From 2010 to 2022, 1194 studies were published in the <i>Journal of Cachexia, Sarcopenia and Muscle</i>. The United States was the highest contributor, with the most publications and citations and the highest H-index. Italy ranked first for the times cited per item. The main research area was geriatrics and gerontology. von Haehling S was the author with the highest impact. The National Institutes of Health, USA, and the United States Department of Health Human Services funded the maximum number of studies. The top 5 most frequently used keywords in all publications over 12 years were sarcopenia, cachexia, skeletal muscle, body composition and muscle mass. The <i>Journal of Cachexia, Sarcopenia and Muscle</i> was cited the most by <i>Nutrients</i>, and PLOS ONE was cited the most by the <i>Journal of Cachexia, Sarcopenia and Muscle</i>.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Publications in the <i>Journal of Cachexia, Sarcopenia and Muscle</i> have significantly increased from 2010 to 2022, especially in recent years. The United States is still the leader in sarcopenia research. Future submissions to this journal will continue to focus on sarcopenia, cachexia, skeletal muscle, body-composition and muscle mass. The aetiology, molecular mechanisms and outcomes of sarcopenia and cachexia are current research hotspots.</p>\n </section>\n </div>","PeriodicalId":73544,"journal":{"name":"JCSM rapid communications","volume":"7 1","pages":"17-29"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.88","citationCount":"0","resultStr":"{\"title\":\"Publication trends and hot spots in the Journal of Cachexia, Sarcopenia and Muscle: A bibliometric analysis (2010–2022)\",\"authors\":\"Dong-liang Yuan, Wen-qing Xie, Miao He, Deng-jie Yu, Heng-zhen Li, Hong-fu Jin, Guang Yang, Bing-zhou Ji, Wen-feng Xiao, Yu-sheng Li\",\"doi\":\"10.1002/rco2.88\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The <i>Journal of Cachexia, Sarcopenia and Muscle</i> is a quarterly peer-reviewed medical journal published by WILEY since 2010 and has been dedicated to advancing research on chronic diseases, especially cachexia and sarcopenia. Over the past 12 years, sarcopenia research worldwide has significantly changed. This study aimed to investigate different aspects of studies published in this journal.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Using the term ‘Journal of Cachexia, Sarcopenia and Muscle’, we retrieved related publications from the Web of Science and PubMed databases. Studies published in this journal were classified and analysed from different perspectives, such as the number of studies, total citations, times cited per item, H-index, research area, article types, institutions, country and funding agency. The VOS viewer software was used for co-occurrence, bibliographic coupling, co-citation and co-authorship analyses.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>From 2010 to 2022, 1194 studies were published in the <i>Journal of Cachexia, Sarcopenia and Muscle</i>. The United States was the highest contributor, with the most publications and citations and the highest H-index. Italy ranked first for the times cited per item. The main research area was geriatrics and gerontology. von Haehling S was the author with the highest impact. The National Institutes of Health, USA, and the United States Department of Health Human Services funded the maximum number of studies. The top 5 most frequently used keywords in all publications over 12 years were sarcopenia, cachexia, skeletal muscle, body composition and muscle mass. The <i>Journal of Cachexia, Sarcopenia and Muscle</i> was cited the most by <i>Nutrients</i>, and PLOS ONE was cited the most by the <i>Journal of Cachexia, Sarcopenia and Muscle</i>.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Publications in the <i>Journal of Cachexia, Sarcopenia and Muscle</i> have significantly increased from 2010 to 2022, especially in recent years. The United States is still the leader in sarcopenia research. Future submissions to this journal will continue to focus on sarcopenia, cachexia, skeletal muscle, body-composition and muscle mass. The aetiology, molecular mechanisms and outcomes of sarcopenia and cachexia are current research hotspots.</p>\\n </section>\\n </div>\",\"PeriodicalId\":73544,\"journal\":{\"name\":\"JCSM rapid communications\",\"volume\":\"7 1\",\"pages\":\"17-29\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/rco2.88\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JCSM rapid communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/rco2.88\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCSM rapid communications","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/rco2.88","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景 《恶病质、肌肉疏松症与肌肉杂志》是由 WILEY 于 2010 年出版的同行评审医学季刊,一直致力于推动慢性疾病,尤其是恶病质和肌肉疏松症的研究。在过去的 12 年中,全球范围内的肌肉疏松症研究发生了重大变化。本研究旨在调查在该期刊上发表的研究的各个方面。 方法 我们以 "Journal of Cachexia, Sarcopenia and Muscle "为关键词,从 Web of Science 和 PubMed 数据库中检索了相关出版物。我们从研究数量、总引用次数、每项被引次数、H 指数、研究领域、文章类型、机构、国家和资助机构等不同角度对发表在该期刊上的研究进行了分类和分析。使用 VOS 浏览器软件进行共现、书目耦合、共引和合著分析。 结果 从 2010 年到 2022 年,《痛症、肉质疏松症和肌肉杂志》共发表了 1194 篇研究论文。美国是贡献最多的国家,发表的论文最多,被引用的次数最多,H 指数也最高。意大利的单篇引用次数排名第一。von Haehling S 是影响最大的作者。美国国立卫生研究院和美国卫生人类服务部资助的研究数量最多。12 年来,所有出版物中使用频率最高的 5 个关键词是肌肉疏松症、恶病质、骨骼肌、身体成分和肌肉质量。营养素》对《恶病质、肌肉减少症与肌肉杂志》的引用率最高,而《PLOS ONE》对《恶病质、肌肉减少症与肌肉杂志》的引用率最高。 结论 从2010年到2022年,《痛症、肌肉疏松症与肌肉杂志》上的论文数量显著增加,尤其是近年来。美国在肌肉疏松症研究方面仍处于领先地位。本期刊今后的投稿将继续关注肌肉疏松症、恶病质、骨骼肌、身体结构和肌肉质量。肌肉疏松症和恶病质的病因、分子机制和结果是当前的研究热点。
Publication trends and hot spots in the Journal of Cachexia, Sarcopenia and Muscle: A bibliometric analysis (2010–2022)
Background
The Journal of Cachexia, Sarcopenia and Muscle is a quarterly peer-reviewed medical journal published by WILEY since 2010 and has been dedicated to advancing research on chronic diseases, especially cachexia and sarcopenia. Over the past 12 years, sarcopenia research worldwide has significantly changed. This study aimed to investigate different aspects of studies published in this journal.
Methods
Using the term ‘Journal of Cachexia, Sarcopenia and Muscle’, we retrieved related publications from the Web of Science and PubMed databases. Studies published in this journal were classified and analysed from different perspectives, such as the number of studies, total citations, times cited per item, H-index, research area, article types, institutions, country and funding agency. The VOS viewer software was used for co-occurrence, bibliographic coupling, co-citation and co-authorship analyses.
Results
From 2010 to 2022, 1194 studies were published in the Journal of Cachexia, Sarcopenia and Muscle. The United States was the highest contributor, with the most publications and citations and the highest H-index. Italy ranked first for the times cited per item. The main research area was geriatrics and gerontology. von Haehling S was the author with the highest impact. The National Institutes of Health, USA, and the United States Department of Health Human Services funded the maximum number of studies. The top 5 most frequently used keywords in all publications over 12 years were sarcopenia, cachexia, skeletal muscle, body composition and muscle mass. The Journal of Cachexia, Sarcopenia and Muscle was cited the most by Nutrients, and PLOS ONE was cited the most by the Journal of Cachexia, Sarcopenia and Muscle.
Conclusions
Publications in the Journal of Cachexia, Sarcopenia and Muscle have significantly increased from 2010 to 2022, especially in recent years. The United States is still the leader in sarcopenia research. Future submissions to this journal will continue to focus on sarcopenia, cachexia, skeletal muscle, body-composition and muscle mass. The aetiology, molecular mechanisms and outcomes of sarcopenia and cachexia are current research hotspots.